Explore more publications!

Press Releases

Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities
Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers
Grand Park Kodhipparu Launches ‘Island Celebrations: EID – Connect in Paradise’
Valneva Reports Full Year 2025 Audited Consolidated Financial Results
Hypersanté Hosts First Francophone Summit on Longevity and Biohacking in Paris
Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom
CELTIC WOMAN RETURNS TO NORTH AMERICA IN SPRING 2026 WITH HIGHLY ANTICIPATED NEW TOUR
EU Balance of Payments and International Investment Position statistical sources and methods - B.o.p. and i.i.p. e-book

EU Balance of Payments and International Investment Position statistical sources and methods - B.o.p. and i.i.p. e-book

Brunch Is the New NYC Ritual: Here's Where to Find the Most Delicious One This Weekend
NY Rum Fest & Conference takes place in Brooklyn on June 7th
Valneva Reports Nine-Month 2025 Financial Results and Provides Corporate Updates
GBSA connects Pangyo’s innovative companies with global media outlets through the 2025 Pangyo Global Media Meet-Up
Statement on the Cabinet meeting of Wednesday, 17 September 2025

Statement on the Cabinet meeting of Wednesday, 17 September 2025

Deputy President Shipokosa Paulus Mashatile: Heritage Day 2025

Deputy President Shipokosa Paulus Mashatile: Heritage Day 2025

Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates
Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information
Native American Photography Book 'Dancing for Our Tribe' by Sharon Hoogstraten
Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ®
Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions